Outcome of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Progressive Metastatic Neuroendocrine Tumors from a Tertiary Care Center
A majority of patients who were treated with PRRT demonstrated clinical, radiological as well as biochemical positive responses warranting an earlier consideration for this well-tolerated treatment modality.
Authors
- Justin Benjamin (ORCID: https://orcid.org/0000-0001-8003-4355)
- Regi Oommen (ORCID: https://orcid.org/0000-0003-1442-7315)
- Felix Jebasingh (ORCID: https://orcid.org/0000-0001-5903-6110)
- Josh Thomas Georgy (ORCID: https://orcid.org/0000-0002-7119-9710)
- Ashish Singh (ORCID: https://orcid.org/0000-0002-3191-7677)
- David Mathew (ORCID: https://orcid.org/0009-0006-4208-3790)
- Saumya Sara Sunny
- Junita Rachel John
Institutions
- Christian Medical College, Vellore (IN)
- Christian Medical College (IN)
Publication Details
- Journal
- Indian Journal of Endocrinology and Metabolism
- Published
- 2024-11-01
- DOI
- https://doi.org/10.4103/ijem.ijem_372_23
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Christian Medical College, Vellore